Berkeley-based Orbillion reckons it can achieve economic production for cell-cultured Wagyu beef “at around 2,000 liters in scale,” says cofounder and CEO Dr. Patricia Bubner.
Shiok Meats, which had raised more than $30m since 2018, couldn’t see a clear path forward under its own steam.
“It is more likely than not that a CRISPR-enabled cell line will ultimately be necessary [for profitable production at scale],” says Eat Just CEO Josh Tetrick.
“This strategy aligns with our commitment to scaling up responsibly,” says CEO Didier Toubia.
Less than five months after announcing its first commercial-scale cultivated meat plant in Glenview, Illinois, UPSIDE Foods has hit pause…
Funding for cultivated meat peaked at $989m in 2021, dipped slightly to $807m in 2022, then dropped sharply to just $177m in 2023.
The ‘PROFUSE-B8’ bovine myoblasts—muscle progenitor cells—are spontaneously immortalized without the use of genetic engineering.
Finless Foods is not commenting on rumors that it is reducing headcount to extend runway, raise capital, and rebuild at a later time.
But does it make sense to grow a commodity ingredient such as coffee in a bioreactor, or does plant cell culture only make sense for ultra-high-value botanicals such as saffron?
Phytolon aims to launch natural colors produced by genetically engineered baker’s yeast in the US this year, pending regulatory approvals.
Cultivated meat startup GOOD Meat has upped the ante in its increasingly ugly legal dispute with bioreactor specialist ABEC over alleged nonpayment of bills by filing a series of counterclaims.
Ayana Bio has signed a deal with Wooree Green Science to develop saffron and other bioactives made via plant cell culture.
We’re kidding ourselves if we think we can make the unit economics add up for cultivated meat without deploying ‘much much larger’ bioreactors, says Ark Biotech.
Israel’s Ministry of Health has issued a “no questions” letter granting the company pre-approval for its cultivated beef steaks.
Who will fund cultivated meat facilities if VC funds are no longer willing to stump up cash for capex projects?
Bioreactor specialist ABEC claims it is owed $100m in cash and stock for work done on Eat Just’s GOOD Meat cultivated meat business.
To find out, foodtech editor Elaine Watson fired off a few emails to startups she’s covered on AgFunderNews this year to get a sense of what is disrupting their sleep, with a particular emphasis on the alt protein space.
The UMAMI/Cell AgriTech facility in Malaysia—the first phase of which is set to come online in Q1, 2025—has a projected annual output of 3,000+ tons (6 million pounds) of cultivated meat/seafood.
Meatiply’s focus on the production of complex value-added compounds using animal cells will allow it to create cultivated meat products with added health benefits, claims the startup.
Investors were pushing cultivated meat startups “to grow as quick and as big as possible while the technologies were not yet mature enough,” says Aleph Farms CEO Didier Toubia.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first